CIPLA
|
The Current P/B Ratio of CIPLA is 4.37.
Share Price | ₹1,441.7 | Mar 28,2025 |
Market Cap | ₹116,431.7 Cr | |
Book Value | ₹26,619.9 Cr | Mar2024 - Consolidated Results |
Price/Book | 4.37x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of CIPLA
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹116,431.7 Cr] as on Mar 28,2025
(/) Book Value [ ₹26,619.9 Cr] based on Mar2024 - Consolidated Results
(=) P/B Ratio [ 4.37x ]
Thus, for CIPLA , the investors are currently willing to pay '4.37 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of CIPLA !
The chart below summarizes the trend in P/B Ratio of CIPLA over the last five years.
Historical PB (Price/Book ) ratio chart of CIPLA
PB Ratio Performance Analysis for CIPLA
- CIPLA 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 3.47x.
- CIPLA 's operated at median p/b ratio of 3.6x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, CIPLA 's p/b ratio peaked in Mar2024 at 4.53x.
- CIPLA 's p/b ratio hit its five-year low in Mar2020 of 2.17x.
How does CIPLA 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
CIPLA | 26,619.90 | 4.37 | 116,431.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.54 | 416,393.0 |
DIVIS LABORATORIES LTD | 13,571.00 | 11.29 | 153,258.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 15.97 | 109,474.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 3.39 | 95,465.9 |
MANKIND PHARMA LTD | 9,339.84 | 10.70 | 99,974.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 4.49 | 89,122.1 |
LUPIN LTD | 14,175.80 | 6.53 | 92,522.9 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.26 | 67,355.6 |
ABBOTT INDIA LTD | 3,658.73 | 17.85 | 65,300.5 |
ALKEM LABORATORIES LTD | 10,292.50 | 5.67 | 58,347.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs CIPLA 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.26x |
Max industry PB | 17.85x |
Median industry PB | 6.53x |
Average industry PB | 8.10x |
You may also like the below Video Courses